On September 29, OPPO pushed a system update for the newly released OPPOWatch3Pro, and the ECG analysis prompt software was officially launched. This time, it is available in OPP Watch 3 Pro at once, further improving the health monitoring capabilities of OPPO wearable products. As the core of the human body, the heart provides power for the operation of the whole body, and its health is an important indicator of physical fitness. The ECG analysis prompt software configured in OPPOWatch3Pro has obtained the Class II medical device registration certificate from the State Food and Drug Administration (Registration Certificate No.: Guangdong Medical Injection Approval 20222211225). With the support of ECG analysis prompt software, adult sinus rhythm and atrial fibrillation can be prompted in 30 seconds. After the measurement is completed, users can obtain the electrocardiogram analysis report results on the watch and mobile phones, helping users proactively pay attention to heart health and obtain a better home health management experience.